Search hospitals > Illinois > Belleville
Southwest Illinois Health Services LLP
Claim this profileBelleville, Illinois 62226
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
126 reported clinical trials
1 medical researcher
Summary
Southwest Illinois Health Services LLP is a medical facility located in Belleville, Illinois. This center is recognized for care of Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Southwest Illinois Health Services LLP is involved with conducting 126 clinical trials across 330 conditions. There are 1 research doctors associated with this hospital, such as Bryan A. Faller.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at Southwest Illinois Health Services LLP
Non-Small Cell Lung Cancer
Bladder Cancer
Breast Cancer
Lung Cancer
Bladder Carcinoma
Cancer
Melanoma
Cutaneous Melanoma
Anal Cancer
Squamous Cell Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Southwest Illinois Health Services LLP?
Southwest Illinois Health Services LLP is a medical facility located in Belleville, Illinois. This center is recognized for care of Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Southwest Illinois Health Services LLP is involved with conducting 126 clinical trials across 330 conditions. There are 1 research doctors associated with this hospital, such as Bryan A. Faller.